To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

NCT00946608 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy

Interventions

DRUG: Loratadine 10 mg Tablets Under Fasting Conditions (Sandoz, Inc.)
DRUG: Loratadine 10 mg Tablets Under Fed Conditions (Sandoz, Inc.)
DRUG: Claritin (Loratadine) 10 mg Tablets Under Fed Conditions (Schering)

Sponsor

Sandoz